Results 31 to 40 of about 140 (98)

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Continuous intraoperative neuromonitoring of the recurrent laryngeal nerve during lung operations. [PDF]

J Thorac Dis, 2023
Kirschbaum A, Jochens N, Stay D, Meyer C, Bartsch DK.   +4 more
europepmc   +1 more source

Application of a continuous respiratory sound monitoring system in thoracic surgery. [PDF]

J Biomed Res, 2021
Wang H, Toker A, Abbas G, Wang LY.
europepmc   +1 more source

Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours. [PDF]

Br J Cancer, 2022
Konstantinopoulos PA, Cheng SC, Supko JG, Polak M, Wahner-Hendrickson AE, Ivy SP, Bowes B, Sawyer H, Basada P, Hayes M, Curtis J, Horowitz N, Wright AA, Campos SM, Ivanova EV, Paweletz CP, Palakurthi S, Liu JF, D'Andrea AD, Gokhale PC, Chowdhury D, Matulonis UA, Shapiro GI.   +22 more
europepmc   +1 more source

Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction. [PDF]

Cytotherapy, 2022
Blitzer GC, Rogus-Pulia NM, Mattison RJ, Varghese T, Ganz O, Chappell R, Galipeau J, McDowell KA, Meyers RO, Glazer TA, Kimple RJ.   +10 more
europepmc   +1 more source

Acoustic spectroscopy and electrical characterization of SiO2/Si structures with ultrathin SiO2 layers formed by nitric acid oxidation

Open Physics, 2009
Bury Peter, Kobayashi Hikaru, Takahashi Masao, Imamura Kentaro, Sidor Peter, ÄŒernobila FrantiÅ¡ek   +5 more
doaj   +1 more source

A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies. [PDF]

Cancer Chemother Pharmacol, 2021
Collier KA, Valencia H, Newton H, Hade EM, Sborov DW, Cavaliere R, Poi M, Phelps MA, Liva SG, Coss CC, Wang J, Khountham S, Monk P, Shapiro CL, Piekarz R, Hofmeister CC, Welling DB, Mortazavi A.   +17 more
europepmc   +1 more source

A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors. [PDF]

Cancer, 2020
Santana VM, Sahr N, Tatevossian RG, Jia S, Campagne O, Sykes A, Stewart CF, Furman WL, McGregor LM.   +8 more
europepmc   +1 more source

An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment. [PDF]

Pharmaceutics, 2023
Carrión-Marchante R, Pinto-Díez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B, González VM, Martín ME.   +11 more
europepmc   +1 more source

Illuminating the path to oncolysis: rise of microbial phototherapy. [PDF]

J Nanobiotechnology
Wu B, Lv X, Kang S, Sun J, Yao S, Liu M, Zhang R, Zhang H.   +7 more
europepmc   +1 more source